NCI Navigant Consulting Inc.

Hospitals Could Save $23 Billion Annually by Streamlining Supply Chain Operations, Product Use

Hospitals nationwide could reduce annual supply expenses by approximately $23 billion in aggregate through improvements in supply chain operations, processes, and product use, according to a Navigant analysis of more than 2,300 hospitals. This represents a 17.8 percent average total supply expense reduction opportunity or up to $9.9 million a year per hospital – an amount equivalent to the annual salaries of 150 registered nurses, or the cost of 4,000 cardiac defibrillators or five Da Vinci robots.

The analysis also shows lower supply spending does not have to reduce quality, as hospital-acquired condition and value-based purchasing scores are slightly better at top-performing supply chain facilities. Moreover, the chance to realize savings may exist for all types of hospitals, with opportunities relatively equal across such characteristics as size, regional location, and whether the facility is urban or rural, for-profit or not-for-profit, or system-based or standalone. To view these results, visit www.navigant.com/SupplyChainAnalysis.

“The pressure on hospitals and health systems to reduce costs and maintain quality will only intensify, no matter the outcome of healthcare reform,” said Christine Torres, system VP of supply chain management for Philadelphia-based Main Line Health. “The supply chain represents close to a third of the average hospital’s overall operating expense, and it’s predicted to surpass labor as a hospital’s greatest expense by 2020. Opportunities exist for all organizations, even top performers, to improve supply chain efficiencies while continuing to offer the highest levels of care to the communities we serve.”

Provider Best Practices

The study found that the top 24 percent* of 2,331 U.S. hospitals analyzed spent $23 billion less a year than other facilities on supply chain products and related operations, processes, and procedures. Savings could be achieved if the remaining 76 percent of hospitals perform at the level of top performers for supply chain budget efficiency.

Top performers consistently leverage evidence-based protocols and data analytics to reduce variation in pricing, product use, and clinical outcomes. This information better equips supply departments to:

  • Reduce the number of suppliers and contracts for like items, particularly with products needed for routine procedures.
  • Optimize the type and frequency of products used based on specific patient circumstances and cases.
  • Engage physicians to standardize use of implantable devices proven to produce clinically equivalent outcomes at a lower cost.
  • Automate requisitions, purchase orders, invoices, and other manual supply chain processes that can lead to documentation errors.

“It’s clear that some hospitals have the appropriate strategies and processes in place to efficiently manage supply chain budgets while maintaining high-quality outcomes,” said Rob Austin, associate director at Navigant. “For example, we have found, somewhat counterintuitively, that the highest-performing providers are simultaneously able to decrease cost and improve quality, in part by reducing clinical variation. Lower-performing supply chain departments need to leverage these types of proven best practices to drive care delivery improvements.”

Benchmarking data is also essential, but providers must look outside their organization to obtain a true snapshot of performance.

“In-hospital benchmarks and year-over-year improvement goals are valuable in monitoring internal supply chain performance, but these measures don’t reveal an organization’s true improvement potential,” said Paul Weintraub, director at Navigant. “To accurately uncover efficiency opportunities, providers must look beyond their facility’s four walls and leverage industry-wide benchmarking data that compares their supply performance against that of their peers.”

To access Navigant’s supply chain benchmarking calculator, visit www.navigant.com/supplysavings.

*Analysis Methodology

Publicly available data from Definitive Healthcare (2015-2017) was reviewed across four key performance indicators (KPIs) for supply expense: per case mix index (CMI) adjusted patient day; per CMI adjusted discharge; as a percent of total operating expense; and, as a percent of net patient revenue. Hospitals were divided into 12 peer groups based on CMI and adjusted occupied bed count, and 560 of 2,331 (24 percent) with savings opportunities of less than 5 percent of total supply expense across each KPI were designated top performers.

Navigant’s Healthcare practice is comprised of more than 500 consultants, former provider administrators, clinicians, and other experts with decades of strategy, operational/clinical consulting, managed services, revenue cycle management, and outsourcing experience. Experts collaborate with hospitals and health systems, physician enterprises, payers, and government entities, providing enterprise-wide strategic development and performance improvement solutions.

About Navigant

Navigant Consulting, Inc. (NYSE: NCI) is a specialized, global professional services firm that helps clients take control of their future. Navigant’s professionals apply deep industry knowledge, substantive technical expertise, and an enterprising approach to help clients build, manage, and/or protect their business interests. With a focus on markets and clients facing transformational change and significant regulatory or legal pressures, the firm serves clients in the healthcare, energy, and financial services industries. Across a range of advisory, consulting, outsourcing, and technology/analytics services, Navigant’s practitioners bring sharp insight that pinpoints opportunities and delivers powerful results. More information about Navigant can be found at www.navigant.com.

EN
13/09/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Navigant Consulting Inc.

NAVIGANT CNSL.INCO. is slightly downgraded to Slightly Positive due to...

The independent financial analyst theScreener just slightly lowered the general evaluation of NAVIGANT CNSL.INCO. (US), active in the Business Support Services industry. As regards its fundamental valuation, the title confirms its rating of 3 out of 4 stars while its market behaviour remains unchanged and can be qualified as defensive. However, a marginally less favourable environment forces theScreener to downgrade slightly the title, which now shows an overall rating of Slightly Positive. As o...

Valens Research
  • Valens Research

Valens Equity Insights and Inflections - 2019 04 17

BZH currently trades near recent lows relative to UAFRS-based (Uniform) Earnings, with a 6.7x Uniform P/E. At these levels, the market is pricing in expectations for Uniform ROA to decline from 11% in 2018 to 5% in 2023, accompanied by 1% Uniform Asset growth going forward. However, analysts have bullish expectations, projecting Uniform ROA to expand to 13% through 2020, accompanied by 3% Uniform Asset shrinkage. Moreover, management is confident in structural plan options, their balanced growth...

Valens Research
  • Valens Research

NCI - Embedded Expectations Analysis - 2019 04 11

Navigant Consulting Inc. (NCI:USA) currently trades below recent averages relative to UAFRS-based (Uniform) Earnings, with a 15.6x Uniform P/E. Even at these levels, the market is pricing in expectations for Uniform ROA to improve from a low of 9% in 2018 to 11% in 2023. Specifically, markets appear optimistic about the competitive position of the firm's remaining industry segments and the potential to drive top-line growth. However, they may be skeptical of the benefits of a simplified portfol...

MarketLine Department
  • MarketLine Department

ICF International, Inc. - Mergers & Acquisitions (M&A), Partnerships &...

Summary Marketline's ICF International, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by ICF International, Inc. since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of th...

2 directors sold after exercising options/sold

Two Directors at Navigant Consulting Inc sold after exercising options/sold 49,598 shares at between 24.120USD and 24.240USD. The significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch